ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
4 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial
|
|
EML333
|
276 |
140K |
3 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
276
|
140K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
2 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts BLA for RYONCIL and Agrees to Priority Review
|
|
EML333
|
131 |
54K |
13 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
131
|
54K
|
13
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
3 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
2 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
HRO |
Re:
Ann: WNB launches Micro-19 Anti-Bacterial Sanitiser
|
|
EML333
|
138 |
56K |
0 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
138
|
56K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
EML333
|
311 |
166K |
9 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
EML333
|
311 |
166K |
4 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
EML333
|
311 |
166K |
9 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
EML333
|
2.0K |
721K |
0 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
2.0K
|
721K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
1 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
1
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
2 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
909
|
355K
|
2
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
4 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
909
|
355K
|
4
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
1 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
909
|
355K
|
1
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
2 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
909
|
355K
|
2
|
|
ASX - By Stock
|
APT |
Re:
Falling daily COVID-19 Cases
|
|
EML333
|
15 |
4.3K |
0 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
15
|
4.3K
|
0
|
|
ASX - By Stock
|
APT |
Re:
Falling daily COVID-19 Cases
|
|
EML333
|
15 |
4.3K |
3 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
15
|
4.3K
|
3
|
|
ASX - By Stock
|
APT |
Re:
Falling daily COVID-19 Cases
|
|
EML333
|
15 |
4.3K |
4 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
15
|
4.3K
|
4
|
|
ASX - By Stock
|
APT |
Re:
back to 20
|
|
EML333
|
463 |
172K |
0 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
463
|
172K
|
0
|
|
ASX - By Stock
|
APT |
Re:
back to 20
|
|
EML333
|
463 |
172K |
0 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
463
|
172K
|
0
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
909
|
355K
|
1
|
|
ASX - By Stock
|
APT |
Re:
what is bottom
|
|
EML333
|
909 |
355K |
4 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
909
|
355K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
4 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
730
|
307K
|
4
|
|